Camp4 Therapeutics (CAMP) Change in Accured Expenses (2023 - 2026)

Camp4 Therapeutics has disclosed Change in Accured Expenses across 4 years of filings, most recently posting -$1.4 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$1.4 million, up 50.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 230.48% YoY), and the FY2025 annual result was $805000.0, down 47.42% from the prior year.
• Change in Accured Expenses came in at -$1.4 million for Q1 2026 at Camp4 Therapeutics, down from $1.2 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q4 2024 to a low of -$2.8 million in Q1 2025.
• The 4-year median for Change in Accured Expenses is $639500.0 (2023), against an average of $152900.0.
• Across the five-year window, Change in Accured Expenses jumped 227.58% in 2024 and tumbled 721.88% in 2025, its largest moves.
• Camp4 Therapeutics' Change in Accured Expenses stood at $562000.0 in 2023, then surged by 227.58% to $1.8 million in 2024, then sank by 34.93% to $1.2 million in 2025, then tumbled by 214.27% to -$1.4 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.4 million (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.